524715:BOM
Sun Pharmaceutical Industries Ltd
₹1,760.60
arrow_upward
+0.67%(+11.70) 1D
Oct 15, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 524715...
Open
₹1,730.00
High
₹1,777.40
Low
₹1,730.00
Mkt. cap
4.23T
Avg. vol.
103.70K
Volume
77.49K
Dividend
0.91%
Quarterly dividend
₹4.00
Ex-dividend date
Jul 7, 2026
P/E ratio
34.90
52-wk high
₹2,047.55
52-wk low
₹1,583.60
EPS
₹50.44
Shares outstanding
0.00
No. of employees
47K
Open
₹1,730.00
High
₹1,777.40
Low
₹1,730.00
Mkt. cap
4.23T
Avg. vol.
103.70K
Volume
77.49K
Dividend
0.91%
Quarterly dividend
₹4.00
Ex-dividend date
Jul 7, 2026
P/E ratio
34.90
52-wk high
₹2,047.55
52-wk low
₹1,583.60
EPS
₹50.44
Shares outstanding
0.00
No. of employees
47K
News stories
From web sources and news partners
ad-hoc-news.de
·
1 hour ago
Analyst consensus puts Sun Pharma stock at INR 2,180.00
ad-hoc-news.de
·
5 hours ago
Sun Pharma approves INR 100.0 billion plan: Sun Pharma stock sits 13.79 percent below high
ad-hoc-news.de
·
2 days ago
Geojit raises target for Sun Pharma stock to INR 2,070.00
TipRanks
·
2 days ago
Sun Pharma Clears INR 10,000 Crore NCD Plan as Independent Director Resigns
Profile
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. It manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world.
Around 70% of Sun Pharma’s revenue is generated from international markets. The US and India are the largest markets, accounting for over 60% of the company's turnover. Manufacturing is across 43 locations in India, the US, Asia, Africa, Australia and Europe. The products cater to therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals. Its active pharmaceutical products include baricitinib, brivaracetam, and dapaglifozin. Wikipedia
About Sun Pharmaceutical Industries Ltd
CEO-
Employees47K
Founded1983
HeadquartersGoregaon East, Mumbai, India
SectorPharmaceutical industry
Websitesunpharma.com